ArticleJournal of ovarian research2019

Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53.

Phong Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.